T1	Participants 31 113	post-menopausal women treated with oral estrogens administered at different times.
T2	Participants 271 305	twenty-four post-menopausal women.
T3	Participants 332 391	one of the two treatment groups by random sampling numbers.
T4	Participants 488 511	Group A patients (n: 9)
T5	Participants 545 569	group B patients (n: 12)
